- Home
- NPO vs ACLX Comparison
NPO vs ACLX Comparison
Compare NPO & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPO
- ACLX
- Stock Information
- Founded
- NPO 2002
- ACLX 2015
- Country
- NPO United States
- ACLX United States
- Employees
- NPO N/A
- ACLX N/A
- Industry
- NPO Metal Fabrications
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- NPO Industrials
- ACLX Health Care
- Exchange
- NPO Nasdaq
- ACLX Nasdaq
- Market Cap
- NPO 4.6B
- ACLX 4.4B
- IPO Year
- NPO N/A
- ACLX 2022
- Fundamental
- Price
- NPO $223.12
- ACLX $85.59
- Analyst Decision
- NPO Buy
- ACLX Strong Buy
- Analyst Count
- NPO 3
- ACLX 12
- Target Price
- NPO $223.33
- ACLX $114.75
- AVG Volume (30 Days)
- NPO 138.8K
- ACLX 483.7K
- Earning Date
- NPO 11-04-2025
- ACLX 11-06-2025
- Dividend Yield
- NPO 0.54%
- ACLX N/A
- EPS Growth
- NPO 97.53
- ACLX N/A
- EPS
- NPO 3.99
- ACLX N/A
- Revenue
- NPO $1,080,600,000.00
- ACLX $56,979,000.00
- Revenue This Year
- NPO $7.28
- ACLX N/A
- Revenue Next Year
- NPO $5.60
- ACLX $210.71
- P/E Ratio
- NPO $57.17
- ACLX N/A
- Revenue Growth
- NPO 4.99
- ACLX N/A
- 52 Week Low
- NPO $133.50
- ACLX $47.86
- 52 Week High
- NPO $234.63
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- NPO 49.68
- ACLX 72.23
- Support Level
- NPO $218.60
- ACLX $76.63
- Resistance Level
- NPO $234.63
- ACLX $89.31
- Average True Range (ATR)
- NPO 6.56
- ACLX 2.82
- MACD
- NPO 0.27
- ACLX 0.51
- Stochastic Oscillator
- NPO 37.47
- ACLX 70.73
About NPO Enpro Inc.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.